AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| USV | Ann: USV NTA 23-04-2018 $2.91343 | 24/04/18 | 0 | 6 | |||
|
|||||||
| USV | Ann: USV NTA 20-04-2018 $2.90002 | 23/04/18 | 0 | 11 | |||
|
|||||||
| USV | Ann: USV NTA 19-04-2018 $2.88893 | 20/04/18 | 0 | 16 | |||
|
|||||||
| USV | Ann: USV NTA 18-04-2018 $2.89146 | 19/04/18 | 0 | 24 | |||
|
|||||||
| USV | Ann: USV NTA 17-04-2018 $2.86213 | 18/04/18 | 0 | 21 | |||
|
|||||||
| USV | Ann: USV NTA 16-04-2018 $2.83752 | 17/04/18 | 0 | 19 | |||
|
|||||||
| USV | Ann: USV NTA 13-04-2018 $2.84197 | 16/04/18 | 0 | 15 | |||
|
|||||||
| USV | Ann: USV NTA 12-04-2018 $2.81619 | 13/04/18 | 0 | 19 | |||
|
|||||||
See All Discussions
NZX News